Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Phosphonimide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102933589A details high-yield asymmetric Strecker reactions using novel N-phosphonimides, offering >99% ee for pharmaceutical intermediate manufacturing.
Novel iron-catalyzed route avoids explosive azides. High yield, scalable process for pharmaceutical intermediates. Cost-effective supply chain solution.